Literature DB >> 21800360

Adamts5 (aggrecanase-2) is widely expressed in the mouse musculoskeletal system and is induced in specific regions of knee joint explants by inflammatory cytokines.

James D Wylie1, Jason C Ho, Shweta Singh, Daniel R McCulloch, Suneel S Apte.   

Abstract

ADAMTS5 (aggrecanase-2) is an extracellular matrix-degrading protease implicated in cartilage destruction in arthritis. Our goals were to determine expression sites of Adamts5 in the murine musculoskeletal system and in an ex vivo joint inflammation model. In mice with an intragenic LacZ reporter controlled by the Adamts5 promoter, β-galactosidase staining was used to identify Adamts5 expressing cells. Mice expressing one wild-type Adamts5 allele were used to determine distribution of Adamts5 mRNA, cleaved aggrecan and versican, and the ADAMTS5 activating enzymes furin and PACE4. Quantitative RT-PCR and immunoblotting were used to validate the immunohistochemistry results. Adamts5 was expressed in mouse synovium, tenosynovium, bone marrow sinusoids, tendons, ligaments, ligament insertions, periosteal cells, and bone vasculature. In knee joint explants treated with IL-1α and TNFα, Adamts5 expression was induced in tenocytes, synovium, and in patellar, but not femoral or tibial articular cartilage. In contrast, increased proteoglycan breakdown in tibial and femoral articular cartilage was associated with increased immunohistochemical staining of PACE4 and furin. These studies identify diverse cell types in the musculoskeletal system that express Adamts5. They also suggest that Adamts5 induction in joint components other than cartilage, and its post-translational activation by PACE4 and/or furin may be important in the pathophysiology of arthritis.
Copyright © 2011 Orthopaedic Research Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21800360     DOI: 10.1002/jor.21508

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.494


  11 in total

Review 1.  The biology of the extracellular matrix: novel insights.

Authors:  Dirk Hubmacher; Suneel S Apte
Journal:  Curr Opin Rheumatol       Date:  2013-01       Impact factor: 5.006

Review 2.  Cartilage damage in osteoarthritis and rheumatoid arthritis--two unequal siblings.

Authors:  Thomas Pap; Adelheid Korb-Pap
Journal:  Nat Rev Rheumatol       Date:  2015-07-21       Impact factor: 20.543

Review 3.  The biology and therapeutic targeting of the proprotein convertases.

Authors:  Nabil G Seidah; Annik Prat
Journal:  Nat Rev Drug Discov       Date:  2012-05       Impact factor: 84.694

4.  Validation of the Diagnostic and Prognostic Values of ADAMTS5 and FSTL1 in Osteoarthritis Rat Model.

Authors:  Bakheet E M Elsadek; Ahmed A Abdelghany; Mohamed A Abd El-Aziz; Hafez R Madkor; Ahmed Abd Elrady Ahmed; Sary Kh Abd-Elghaffar; Amer Alkot Mostafa Elsadek
Journal:  Cartilage       Date:  2019-06-10       Impact factor: 3.117

5.  AKAP12 ameliorates liver injury via targeting PI3K/AKT/PCSK6 pathway.

Authors:  Xuan Wu; Yuhong Luo; Shan Wang; Yueying Li; Meiyu Bao; Yuanjiang Shang; Lei Chen; Weiwei Liu
Journal:  Redox Biol       Date:  2022-05-06       Impact factor: 10.787

6.  Cross-Talk Between Human Tenocytes and Bone Marrow Stromal Cells Potentiates Extracellular Matrix Remodeling In Vitro.

Authors:  Emmanuel C Ekwueme; Jay V Shah; Mahir Mohiuddin; Corina A Ghebes; João F Crispim; Daniël B F Saris; Hugo A M Fernandes; Joseph W Freeman
Journal:  J Cell Biochem       Date:  2015-09-29       Impact factor: 4.429

7.  FURIN Inhibition Reduces Vascular Remodeling and Atherosclerotic Lesion Progression in Mice.

Authors:  Gopala K Yakala; Hector A Cabrera-Fuentes; Gustavo E Crespo-Avilan; Chutima Rattanasopa; Alexandrina Burlacu; Benjamin L George; Kaviya Anand; David Castaño Mayan; Maria Corlianò; Sauri Hernández-Reséndiz; Zihao Wu; Anne M K Schwerk; Amberlyn L J Tan; Laia Trigueros-Motos; Raphael Chèvre; Tricia Chua; Robert Kleemann; Elisa A Liehn; Derek J Hausenloy; Sujoy Ghosh; Roshni R Singaraja
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-03       Impact factor: 8.311

8.  Connexin43 Mediated Delivery of ADAMTS5 Targeting siRNAs from Mesenchymal Stem Cells to Synovial Fibroblasts.

Authors:  Shuo Liu; Corinne Niger; Eugene Y Koh; Joseph P Stains
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

Review 9.  Current and emerging therapeutic strategies for preventing inflammation and aggrecanase-mediated cartilage destruction in arthritis.

Authors:  Carolyn M Dancevic; Daniel R McCulloch
Journal:  Arthritis Res Ther       Date:  2014       Impact factor: 5.156

10.  ADAMTS5 is required for normal trabeculated bone development in the mandibular condyle.

Authors:  A W Rogers-DeCotes; S C Porto; L E Dupuis; C B Kern
Journal:  Osteoarthritis Cartilage       Date:  2021-02-06       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.